Search for: "BRISTOL-MYERS SQUIBB" Results 661 - 680 of 863
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Jan 2009, 3:35 am
Just to recap then, the High Court of Delhi recently granted an ex parte restraining order in favour of Bristol Myers Squibb restraining the defendants, Hetero Drugs (an Indian generic firm) from manufacturing, selling, distributing, advertising, exporting, offering for sale or in any manner dealing directly or indirectly in any product infringing the plaintiffs product patent covering Dasatinib, a drug used in the treatment of Chronic Myloeid Leukemia. [read post]
15 Dec 2008, 9:51 pm by Aaron Barkoff
  The '265 patent covers clopidogrel bisulfate, the active ingredient in Sanofi and Bristol-Myers Squibb's blockbuster heart medication Plavix. [read post]
12 Sep 2020, 4:41 am by SHG
His 2017 win in Bristol Myers Squibb v. [read post]
24 Mar 2010, 4:45 am
(Patent Docs) Reyataz (Atazanavir): US: Patent infringement complaint filed following a Paragraph IV certification: Bristol-Myers Squibb Co. et al. v. [read post]
26 Jun 2017, 3:34 am by Liz Dunshee
And tune in for our October 10 webcast – “E&S Disclosures: The In-House Perspective” – featuring experts from the Coca-Cola Company, Bristol-Myers Squibb, Apple & Clorox. [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) - US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA Director General (IP Watch) Is the… [read post]
4 Dec 2007, 6:33 pm
Bristol-Myers Squibb was the first company to develop and patent a liquid pharmaceutical composition of megestrol acetate and had a patent that taught that stable suspensions of megestrol acetate can be created but that the type and concentration of the surfactant in solution is critical to creating a stable flocculated suspension. [read post]
24 Oct 2017, 7:00 am by Altman & Altman
Out-of-State Restrictions In a case involving Bristol-Myers Squibb, the Missouri Supreme Court ruled in June 2017 that courts only have jurisdiction over an out-of-state claim if there exists an “affiliation between the forum and the underlying controversy, principally, [an] activity or an occurrence that takes place in the forum State. [read post]
3 Jun 2008, 3:05 am
The following table also provides some interesting comparisons of patent strategy.[6] Type of Technology Number of Utility Patents in the Sample Number of Patents Referencing Provisional Parent Assignee Mechanical 24 1 4% Ford 25 13 52% GM Drugs & Medical 7 4 57% Wyeth 8 7 88% Genentech 11 1 9% Boston Scientific Scimed 21 10 48% Medtronic Computers & Communications 15 12 80% InterDigital 23 7 30% Oracle 31 11 35% QUALCOMM 44… [read post]
22 Dec 2011, 5:01 am by Lawrence Higgins
[Link] Bristol-Myers Squibb is seeking an IP Counsel with 5+ years of patent attorney experience and a background in molecular biology or biochemistry to work at their New Jersey location. [read post]
25 Aug 2015, 10:55 am by Duets Guest Blogger
The cases of Bristol-Myers Squibb v Paranova and Boehringer II in particular held that where a parallel importer re-packages goods, the following conditions must be satisfied to prevent infringement: The repacking must be objectively necessary to avoid market partitioning; The condition of the product must not be effected; The manufacturer and the importer must be clearly identified; The reputation of the mark and its owner must not be damaged; and The importer must give… [read post]
18 Aug 2010, 12:19 am by Kelly
(IP Whiteboard) Australia: A tale of four amendment requests: Bristol-Myers Squibb Company v. [read post]
7 Dec 2009, 2:12 am by Kevin LaCroix
Most notably, the parties to the Bristol- Myers Squibb securities class action lawsuit agreed to settle that case for $300 million while the case was on appeal to the Third Circuit following the district court’s dismissal. [read post]
22 Oct 2018, 1:43 am by Sara Parrello
Indeed, both Upjohn and before Bristol-Myers Squibb and Others v Paranova (joined Cases C-427/93, 429/93 and 436/93) had indicated that “the requirement of artificial partitioning of the markets does not imply that the importer must demonstrate (emphasis added) that, by putting an identical product on the market in varying forms of packaging in different Member States, the trade mark proprietor deliberately sought to partition the markets between Member… [read post]
22 Aug 2012, 7:51 am by arester
Bristol-Myers Squibb Co., resulting in $515 million settlement arising from unlawful conduct including off-label promotion to induce government purchases of the antipsychotic drug Abilify; and United States ex rel. [read post]
25 Jan 2019, 12:00 am by David Lopez
The first being Bristol Myers Squibb Co’s (BMY) acquisition of Celgene Corp. [read post]
22 Jun 2009, 12:24 pm
The event features a faculty of leading outside litigators and 28 senior in-house counsel from: ACE INA * Aetna * AIG * Aon * AT&T * Bayer * Boeing * Bristol-Myers Squibb * Chubb * Crawford & Co. * CSC * Con Edison * Fidelity * Goodyear * Honeywell * International Paper * JCPenney * Lowe’s * MetLife * Pitney Bowes * Procter & Gamble * Sunoco * TJUH * Unum * Wachovia * Wells Fargo * W.R. [read post]